Hyperuricemia – consequences of not initiating therapy. Benefits and drawbacks of treatment
| Autor: | Igor Domański, Aleksandra Kozieł, Natalia Kuderska, Paulina Wójcik, Tomasz Dudzik, Łucja Dudzik |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Rheumatology, Vol 62, Iss 3, Pp 207-213 (2024) |
| Druh dokumentu: | article |
| ISSN: | 0034-6233 2084-9834 |
| DOI: | 10.5114/reum/189998 |
| Popis: | Hyperuricemia, characterized by elevated levels of uric acid in the body, is associated with several health risks, including gout, urolithiasis and cardiovascular disease. Although treatment options are available, they can lead to hypersensitivity reactions, particularly with allopurinol therapy. This paper provides a comprehensive review of the consequences of hyperuricemia, the need for treatment and the potential adverse effects of allopurinol, illustrated by a case study. The study highlights the importance of careful consideration before initiating therapy, particularly in patients with comorbidities and concomitant medication. It emphasizes the need for vigilant monitoring and individualized treatment approaches to reduce adverse effects. In addition, genetic factors, particularly HLA-B*5801, play an important role in determining susceptibility to allopurinol hypersensitivity reactions. This paper highlights the importance of informed decision making in the management of hyperuricemia to optimize patient outcomes while minimizing the risks associated with treatment. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|